Public research preview

Herzberg, Dr. Max, Vorstand of Vidac Pharma Holding PLC

Disclosed a sell transaction in Vidac Pharma Holding PLC. Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Stadig frisk
100/100
Signalkvalitet
37/100
Datatillid
92%
high

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
BaFin managers' transactions
Published
2 Jun 2026, 11.57
Parser confidence
96%
Instrument mapping
85%
Filing delay
6 days

Timeline

Transaction date

27 May 2026

Public disclosure

2 Jun 2026

Now

Tracked today

Filing delay: 6 days

Price movement

Fallback coverage

Provider
Fixture market data
Fetched
2 Jun 2026

No free fixture-market price coverage for GB00BM9XQ619 / T9G.

Daily stock-price history is unavailable for this signal.

Fallback transaction price
0,58
Fallback disclosure price
0,58
Fallback latest price
0,58
Pre-disclosure move
0.0%
Post-disclosure move
0.0%
Market-adjusted move
0.0%

Why Copy Window is Still fresh

Supporting factors

  • Parsed sell disclosure for ordinary shares from BaFin managers' transactions.
  • Transaction value is EUR 4,350.
  • Post-disclosure move is calculated from Fixture market data daily closes.

Cautions

  • Market-price coverage is fixture-backed until a free public provider is connected.
  • Review the original source document before making any investment decision.

Source document

BaFin managers' transactions, published 2 Jun 2026, 11.57

View source
Parser confidence
96%
Instrument mapping
85%
FieldExtracted value
isinGB00BM9XQ619
roleVorstand
sidesell
price0.58
value4350
sourcebafin_managers_transactions
currencyEUR
assetTypestock
sourceUrlhttps://portal.mvp.bafin.de/database/DealingsInfo/sucheForm.do?emittentName=V&6578706f7274=1&d-4000784-e=3#9c2a60c5661b
personNameHerzberg, Dr. Max
companyNameVidac Pharma Holding PLC
publishedAt2026-06-02T11:57:25.000Z
rawDocumentIdraw-de-bafin-9c2a60c5661b
disclosureDate2026-06-02
transactionDate2026-05-27